Atreca
Patents, Design & Utilities

Last updated:

List of all Atreca patents 11 in total

Status Patent
Application
Utility: ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODE External link
Filling date: 5 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: ANTI-CSP ANTIBODY VARIANTS External link
Filling date: 5 Sep 2025 Issue date: 23 Jun 2022
Application
Utility: USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES External link
Filling date: 5 Sep 2025 Issue date: 19 May 2022
Application
Utility: COMBINATORIAL SETS OF NUCLEIC ACID BARCODES FOR ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS External link
Filling date: 5 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Anti-malarial antibodies that bind circumsporozoite protein External link
Filling date: 5 Sep 2025 Issue date: 20 Jul 2021
Application
Utility: ANTI-HIV ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: ANTI-HIV ANTIBODIES External link
Filling date: 5 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES External link
Filling date: 5 Sep 2025 Issue date: 12 Nov 2020
Application
Utility: ANTIBODIES THAT BIND TUMOR TISSUE FOR DIAGNOSIS AND THERAPY External link
Filling date: 5 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES External link
Filling date: 5 Sep 2025 Issue date: 23 Apr 2020
Grant
Utility: Use of nanoexpression to interrogate antibody repertoires External link
Filling date: 5 Sep 2025 Issue date: 14 Apr 2020

Showing 1 to 11 of 11 patents.